Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

4,126 studies matching your filters

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low TrialRecruiting
NCT07391774Phase 3Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Anatomic Stage II Breast Cancer AJCC v8 · Anatomic Stage IIIA Breast Cancer AJCC v8 · Anatomic Stage IIIC Breast Cancer AJCC v8 · Estrogen Receptor-Positive Breast Carcinoma
United States, Puerto Rico
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)Recruiting
NCT06024746Phase 3Updated Sep 10, 2026
Sponsor: Colorado Prevention Center
Heart Failure
United States, Brazil, Canada, China, India +3 more
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or CarcinosarcomaRecruiting
NCT05256225Phase 3Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Endometrial Carcinoma · Endometrial Clear Cell Adenocarcinoma · Endometrial Dedifferentiated Carcinoma · Endometrial Endometrioid Adenocarcinoma
United States, Puerto Rico, South Korea
CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)Recruiting
NCT06708299Phase 3Updated Sep 10, 2026
Sponsor: Cardiol Therapeutics Inc.
Recurrent Pericarditis
United States, Canada, Greece, Italy
A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's DiseaseRecruiting
NCT07717411Phase 3Updated Sep 10, 2026
Sponsor: Hoffmann-La Roche
Alzheimer's Disease
United States, Canada, China, United Kingdom
Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)Recruiting
NCT07218354Phase 3Updated Sep 10, 2026
Sponsor: VA Office of Research and Development
Alcohol Use Disorder
United States
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular LymphomaRecruiting
NCT06337318Phase 3Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Classic Follicular Lymphoma · Follicular Lymphoma With Unusual Cytological Features
United States
GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia PatientsRecruiting
NCT05316935Phase 2, Phase 3Updated Sep 10, 2026
Sponsor: Xiaojun Chen
Endometrial Neoplasms · Atypical Endometrial Hyperplasia · Progesterone Resistance
China
Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD-L1 Positive (CPS≥1) HNSCCRecruiting
NCT07026474Phase 3Updated Sep 10, 2026
Sponsor: Universität des Saarlandes
Recurrent Head and Neck Squamous Cell Carcinoma
Germany, Switzerland
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade GliomaRecruiting
NCT04166409Phase 3Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Low Grade Astrocytoma · Low Grade Glioma · Metastatic Low Grade Astrocytoma · Metastatic Low Grade Glioma
United States, Canada, Puerto Rico
Efficacy and Safety of Intranasal Cenegermin in Adult Participants With Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)Recruiting
NCT07453888Phase 3Updated Sep 10, 2026
Sponsor: Dompé Farmaceutici S.p.A
Non-Arteritic Anterior Ischemic Optic Neuropathy
United States, Australia, United Kingdom
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung CancerRecruiting
NCT04181060Phase 3Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Advanced Lung Non-Squamous Non-Small Cell Carcinoma · Metastatic Lung Non-Squamous Non-Small Cell Carcinoma · Recurrent Lung Non-Squamous Non-Small Cell Carcinoma · Stage IIIB Lung Cancer AJCC v8
United States
Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate CancerRecruiting
NCT05448547Phase 3Updated Sep 10, 2026
Sponsor: Sven Löffeler
Prostate Cancer
Denmark, Finland, Norway, Sweden
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple SclerosisRecruiting
NCT07299019Phase 3Updated Sep 10, 2026
Sponsor: Zenas BioPharma (USA), LLC
Secondary Progressive Multiple Sclerosis
United States, Croatia, Czechia, Estonia, Italy +4 more
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)Recruiting
NCT06452277Phase 3Updated Sep 10, 2026
Sponsor: Bayer
Advanced Non-small Cell Lung Cancer, HER2 Mutation
United States, Argentina, Australia, Austria, Belgium +31 more
Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT ImagingRecruiting
NCT07613099Phase 3Updated Sep 10, 2026
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Allogeneic Stem Cell Transplantation · Lung Allograft Transplantation · Interstitial Lung Disease · Acute Lung Injury
United States
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBMRecruiting
NCT05902169Phase 3Updated Sep 10, 2026
Sponsor: CarThera
Glioblastoma · Recurrent Glioblastoma · GBM
United States, Austria, Belgium, Denmark, France +6 more
Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated GlioblastomaRecruiting
NCT07452458Phase 3Updated Sep 10, 2026
Sponsor: NRG Oncology
Glioblastoma, IDH-Wildtype · MGMT-Unmethylated Glioblastoma
United States
Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant SchizophreniaRecruiting
NCT07184619Phase 3Updated Sep 10, 2026
Sponsor: Newron Pharmaceuticals SPA
Treatment-resistant Schizophrenia
United States, Argentina, India, Malaysia
BEACON - Phase III Clinical Study of Rugonersen in Angelman Syndrome.Recruiting
NCT07605429Phase 3Updated Sep 10, 2026
Sponsor: OHB Pediatrics Ltd.
Angelman Syndrome
United States
A Clinical Study of SHR-A1811 in Combination With Chemotherapy and Bevacizumab Versus Standard Therapy as First-Line Treatment for Advanced Colorectal CancerRecruiting
NCT07676162Phase 3Updated Sep 10, 2026
Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Advanced Colorectal Cancer
China
A Study Comparing BL-B01D1 in Combination With Osimertinib Versus Osimertinib Alone in Patients With Locally Advanced, Unresectable EGFR-mutated Non-small Cell Lung Cancer(Stage III) Whose Disease Has Not Progressed Following Definitive Platinum-based Chemoradiation Therapy(PANKU-Lung08)Recruiting
NCT07640789Phase 3Updated Sep 10, 2026
Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
Non-small Cell Lung Cancer Stage III
China
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular EdemaRecruiting
NCT07592273Phase 2, Phase 3Updated Sep 10, 2026
Sponsor: AbbVie
Diabetic Retinopathy
United States, Puerto Rico
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by SurgeryRecruiting
NCT03180268Phase 3Updated Sep 10, 2026
Sponsor: NRG Oncology
Grade 2 Meningioma · Intracranial Meningioma
United States, Canada, India, Japan, Saudi Arabia
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )Recruiting
NCT07621718Phase 3Updated Sep 10, 2026
Sponsor: Revolution Medicines, Inc.
Pancreatic Cancer · Pancreatic Cancer Metastatic · PDAC · PDAC - Pancreatic Ductal Adenocarcinoma
United States

4,126 studies found